Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide

Expert Opin Emerg Drugs. 2012 Sep;17(3):279-83. doi: 10.1517/14728214.2012.679263. Epub 2012 Apr 25.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Cushing Syndrome / drug therapy*
  • Cushing Syndrome / etiology
  • Cushing Syndrome / metabolism
  • Humans
  • Mifepristone / administration & dosage
  • Mifepristone / pharmacology
  • Mifepristone / therapeutic use*
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Receptors, Somatostatin / agonists
  • Somatostatin / administration & dosage
  • Somatostatin / analogs & derivatives*
  • Somatostatin / pharmacology
  • Somatostatin / therapeutic use
  • Treatment Outcome

Substances

  • Receptors, Glucocorticoid
  • Receptors, Somatostatin
  • Mifepristone
  • Somatostatin
  • pasireotide